[Treatment of Morgagni-Adams-Stokes syndrome (M.A.S.)].
D000219:Adams-Stokes Syndrome / Q000503:physiopathology / Q000628:therapy*; D001285:Atropine / Q000008:administration & dosage; D004554:Electric Countershock; D004562:Electrocardiography; D004573:Electrolytes / Q000627:therapeutic use; D004809:Ephedrine / Q000008:administration & dosage; D004837:Epinephrine / Q000627:therapeutic use; D006336:Heart Massage; D006801:Humans; D007362:Intensive Care Units; D008012:Lidocaine / Q000627:therapeutic use; D008722:Methods; D010138:Pacemaker, Artificial / Q000009:adverse effects / Q000295:instrumentation; D012151:Resuscitation / Q000295:instrumentation
D004573:Electrolytes; D001285:Atropine; D008012:Lidocaine; D004809:Ephedrine; D004837:Epinephrine
Il trattamento della sindrome di Morgagni-Adams-Stokes (M.A.S.)